Search results
Showing 256 to 270 of 413 results for heart failure
NICE has developed a medtech innovation briefing (MIB) on Butterfly iQ+ for diagnostic ultrasound imaging .
Cardiac resynchronisation therapy for the treatment of heart failure (TA120)
This guidance has been updated and replaced by NICE technology appraisal guidance 314.
Read biographies for all members of NICE's indicator advisory committee.
Read biographies for all members of NICE's indicator advisory committee.
Cardiac contractility modulation device implantation for heart failure (IPG655)
We have moved interventional procedures guidance 655 to become HealthTech guidance 520. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
NICE has developed a medtech innovation briefing (MIB) on CytoSorb therapy for sepsis .
Trastuzumab for the treatment of HER2-positive metastatic gastric cancer (TA208)
Evidence-based recommendations on trastuzumab (Herceptin) for treating HER2-positive metastatic gastric cancer in adults.
Evidence-based recommendations on golimumab (Simponi) for treating rheumatoid arthritis in adults.
NICE has developed a medtech innovation briefing (MIB) on DuraGraft for preserving vascular grafts .
We have moved interventional procedures guidance 807 to become HealthTech guidance 764. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
TactiCath Quartz catheter for percutaneous radiofrequency ablation in atrial fibrillation (MIB60)
NICE has developed a medtech innovation briefing (MIB) on the TactiCath Quartz catheter for percutaneous radiofrequency ablation in atrial fibrillation
Early and locally advanced breast cancer: diagnosis and management (NG101)
This guideline covers diagnosing and managing early and locally advanced breast cancer. It aims to help healthcare professionals offer the right treatments to people, taking into account the person's individual preferences.
ENDURALIFE powered CRT-D devices for treating heart failure (MTG33)
We have moved Medical technologies guidance 33 to become HealthTech guidance 433. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
Permanent His-bundle pacemaker implantation for treating heart failure (IPG694)
We have moved interventional procedures guidance 694 to become HealthTech guidance 579. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
Evidence-based recommendations on multiple frequency bioimpedance devices to guide fluid management in people with chronic kidney disease having dialysis.